Gainers
- Agape ATP (NASDAQ:ATPC) stock rose 61.6% to $0.11 during Thursday's regular session. The company's market cap stands at $3.5 million.
- Nuwellis (NASDAQ:NUWE) stock increased by 26.31% to $2.4. The market value of their outstanding shares is at $1.7 million.
- CNS Pharma (NASDAQ:CNSP) shares increased by 25.96% to $7.81. The market value of their outstanding shares is at $3.8 million.
- ImmunityBio (NASDAQ:IBRX) shares rose 21.02% to $3.65. The company's market cap stands at $2.9 billion.
- Pheton Holdings (NASDAQ:PTHL) shares moved upwards by 17.7% to $0.52. The market value of their outstanding shares is at $7.4 million.
- Atara Biotherapeutics (NASDAQ:ATRA) shares increased by 14.09% to $5.1. The market value of their outstanding shares is at $32.2 million.
Losers
- Inspire Veterinary (NASDAQ:IVP) shares decreased by 42.1% to $0.05 during Thursday's regular session. The company's market cap stands at $3.4 million.
- MetaVia (NASDAQ:MTVA) shares decreased by 36.35% to $3.45. The market value of their outstanding shares is at $12.5 million.
- Agenus (NASDAQ:AGEN) stock fell 20.76% to $3.71. The market value of their outstanding shares is at $159.1 million.
- Akanda (NASDAQ:AKAN) stock fell 18.52% to $1.32.
- Cue Biopharma (NASDAQ:CUE) stock decreased by 16.87% to $0.28. The market value of their outstanding shares is at $31.1 million.
- OKYO Pharma (NASDAQ:OKYO) stock declined by 14.67% to $2.42. The company's market cap stands at $106.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AKANAkanda Corp
$1.31-19.1%
ATPCAgape ATP Corp
$0.113361.9%
ATRAAtara Biotherapeutics Inc
$5.0312.6%
CNSPCNS Pharmaceuticals Inc
$8.3134.1%
CUECue Biopharma Inc
$0.3334-17.8%
IBRXImmunityBio Inc
$3.7022.5%
IVPInspire Veterinary Partners Inc
$0.0467-43.0%
MTVAMetaVia Inc
$3.47-36.0%
NUWENuwellis Inc
$2.3925.8%
OKYOOKYO Pharma Ltd
$2.40-15.2%
PTHLPheton Holdings Ltd
$0.428122.9%
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

